Invitation Letter to Youth Screener

0932 NYTS Att N2 Invitation Letter to Youth Screener.docx

National Youth Tobacco Surveys 2024 2026

Invitation Letter to Youth Screener

OMB: 0910-0932

Document [docx]
Download: docx | pdf

OMB Control Number 0910-0932 

Expiration Date 05/31/2027



Attachment 3

2026 NYTS Cognitive Testing Invitation to Youth Screener

Qualitative Inquiry to Support Tobacco-Related Surveillance


Parent/Guardian Email Invitation for Youth to Complete Screener Survey

Note: After parent/guardian consent has been received, the parent/guardian will be sent this email inviting their child to complete their screener survey.

Dear PARENT NAME

Thank you for agreeing for your child to participate in interviews that will test questions on health and tobacco product use in support of the Food and Drug Administration’s (FDA) efforts to conduct health surveillance.

We request that your child complete a short survey so that we can learn a little more about them. This survey should take about 5 minutes to complete. Your child should complete the survey in private, and their responses to the survey will be kept private by Deloitte. Completing the survey does not guarantee that your child will be selected for an interview.

As a reminder, if your child is selected to participate in the two interviews, they will receive a $50 Amazon gift card after each one-hour interview (total of two $50 gift cards).

Please have your child click the link below to access the survey. The first page of the survey notes that the survey is voluntary and requires their agreement to participate. Following completion of the survey, you will be notified as to whether your child has been selected to participate.

Thank you!



LINK



Sincerely,

Deloitte



Public reporting burden for this collection of information is estimated to average 30 minutes per survey, including time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, PRAStaff@fda.hhs.gov, ATTN: PRA (0910-0932).



2

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleReport Template Blue
AuthorMicrosoft Office User
File Modified0000-00-00
File Created2025-10-30

© 2025 OMB.report | Privacy Policy